Low ADC in CNS Lymphoma - Archive ouverte HAL
Article Dans Une Revue Clinical Nuclear Medicine Année : 2020

Low ADC in CNS Lymphoma

Résumé

Patients with primary central nervous system lymphomas (PCNSLs) present with nonspecific clinical symptoms, which makes correct imaging evaluation essential for diagnostic and therapeutic management. In this work, we examined an 81-year-old man with recently discovered PCNSL using F-FDG PET/MRI, and we were able to differentiate between 2 lesions-PCNSL lymphoma extension and a recent ischemia. Our work shows that ischemia should be considered as a differential diagnosis for lymphoma progression. Although F-FDG PET or MRI alone cannot always give unambiguous solution, PET/MRI can greatly improve the diagnosis accuracy and help decide on the appropriate patient management.
Fichier non déposé

Dates et versions

hal-03139275 , version 1 (11-02-2021)

Identifiants

Citer

Nadya Pyatigorskaya, Damien Galanaud, Didier Dormont, Carole Soussain, Aurelie Kas. Low ADC in CNS Lymphoma. Clinical Nuclear Medicine, 2020, 45 (7), pp.545-546. ⟨10.1097/RLU.0000000000003067⟩. ⟨hal-03139275⟩
44 Consultations
0 Téléchargements

Altmetric

Partager

More